Hypersensitivity to the active ingredient.
Administration to animals with seriously impaired renal and/or hepatic functions.
Concurrent administration of barbiturates, phenylbutazone, glucocorticosteroids or other NSAIDs.
Administration to animals producing milk for human consumption.
Intravenous injection.
Gastrointestinal disorders (nausea, vomiting, diarrhoea), gastric ulcers.
Risk of bleedings, blood dyscrasias.
Renal papillary necrosis.
Long-term use of Castralgin may lead to leukopenia and/or agranulocytosis.
Isolated cases of anaphylactic reactions have been reported.
Special precautions:
Due to possible hypersensitivity reactions, direct skin contact should be avoided during handling of
the product.
Protective gloves should be worn.
Do not administer more than 30 ml in cattle per injection site to favour absorption and dispersion.
For intramuscular administration.
Cattle:
Once 40 mg per kg body weight (corresponding to 8 ml of Castralgin per 100 kg of body weight).
Calves:
Once 40 - 50 mg per kg body weight (corresponding to 8 - 10 ml per 100 kg body weight).
Pigs:
Once 75 - 100 mg per kg body weight (corresponding to 15 - 20 ml per 100 kg body weight).
Dogs:
70 - 100 mg per kg body weight (corresponding to 1.4 - 2 ml per 10 kg body weight). The dose may be repeated if necessary.
Note:
Castralgin can be used safely during gestation and lactation, provided the milk is not destined for human consumption. Do not exceed the maximum injection volume of 30 ml per injection site in cattle.
- For meat:
Cattle: 20 days.
Calves: 28 days.
Pigs: 17 days.
Not for use in cattle producing milk for human consumption